Company at a Glance
Price
Overview
Ono Pharmaceutical Co., Ltd. is a Japanese-based pharmaceutical company that was founded in 1717. The company develops, manufactures, and sells prescription medicines and over-the-counter products for a wide range of medical conditions. Ono Pharmaceutical is headquartered in Osaka, Japan and has operations in Asia, Europe, and the United States.
The company focuses on research and development in the fields of oncology, immunology, and neurology. Its products include treatments for cancer, immune disorders, infectious diseases, and other areas of unmet medical need.
Ono Pharmaceutical is committed to ethical business practices and responsible corporate citizenship. The company has implemented various initiatives to reduce its environmental impact and contribute to the well-being of communities it operates in.
Ono Pharmaceutical has collaborations and partnerships with other pharmaceutical companies, research institutions, and universities to enhance its research capabilities and bring innovative medicines to patients.
Overall, Ono Pharmaceutical is dedicated to improving the health and quality of life of individuals worldwide through the development of innovative and effective medications.
What is special about the company?
📈 Want to read more about Ono Pharmaceutical?
Sign up for free
or
log in
📘 Claim your free eBook: "The Checklist Value Investor — A Smarter Way to Pick Stocks"
MS4gRm9jdX NlZCBvbiBS ZXNlYXJjaC BhbmQgRGV2 ZWxvcG1lbn Q6IE9ubyBQ aGFybWFjZX V0aWNhbCBo YXMgYSBzdH JvbmcgZm9j dXMgb24gcm VzZWFyY2gg YW5kIGRldm Vsb3BtZW50 LCBpbnZlc3 RpbmcgYSBz aWduaWZpY2 FudCBwb3J0 aW9uIG9mIG l0cyByZXZl bnVlIGludG 8gdGhlIGRl dmVsb3BtZW 50IG9mIG5l dyBkcnVncy 4gVGhpcyBo YXMgYWxsb3 dlZCB0aGUg Y29tcGFueS B0byBpbnRy b2R1Y2UgaW 5ub3ZhdGl2 ZSBhbmQgZW ZmZWN0aXZl IHRyZWF0bW VudHMgZm9y IHZhcmlvdX MgZGlzZWFz ZXMuPGJyPj IuIFN0cm9u ZyBQaXBlbG luZSBvZiBE cnVnczogT2 5vIFBoYXJt YWNldXRpY2 FsIGhhcyBh IHJvYnVzdC BwaXBlbGlu ZSBvZiBkcn Vncywgd2l0 aCBzZXZlcm FsIHBvdGVu dGlhbCBibG 9ja2J1c3Rl ciBkcnVncy BpbiBkZXZl bG9wbWVudC 4gVGhpcyBl bnN1cmVzIG EgY29udGlu dW91cyBzb3 VyY2Ugb2Yg cmV2ZW51ZS Bncm93dGgg aW4gdGhlIG Z1dHVyZS48 YnI+My4gR2 xvYmFsIFBy ZXNlbmNlOi BUaGUgY29t cGFueSBoYX MgYSBnbG9i YWwgcHJlc2 VuY2UsIHdp dGggb3Blcm F0aW9ucyBp biBKYXBhbi wgdGhlIFVu aXRlZCBTdG F0ZXMsIGFu ZCBFdXJvcG UuIFRoaXMg YWxsb3dzIG l0IHRvIHRh cCBpbnRvIG RpZmZlcmVu dCBtYXJrZX RzIGFuZCBy ZWFjaCBhIH dpZGVyIHBh dGllbnQgcG 9wdWxhdGlv bi48YnI+NC 4gU3RyYXRl Z2ljIFBhcn RuZXJzaGlw czogT25vIG hhcyBmb3Jt ZWQgc3RyYX RlZ2ljIHBh cnRuZXJzaG lwcyB3aXRo IG90aGVyIH BoYXJtYWNl dXRpY2FsIG NvbXBhbmll cyBhbmQgYm lvdGVjaCBz dGFydHVwcy B0byBkZXZl bG9wIG5ldy BkcnVncyBh bmQgdGVjaG 5vbG9naWVz LiBUaGlzIG NvbGxhYm9y YXRpb24gaG VscHMgdGhl IGNvbXBhbn kgYWNjZXNz IGN1dHRpbm ctZWRnZSBy ZXNlYXJjaC BhbmQgZXhw YW5kIGl0cy Bwcm9kdWN0 IHBvcnRmb2 xpby48YnI+ NS4gQ29tbW l0bWVudCB0 byBJbm5vdm F0aW9uOiBP bm8gUGhhcm 1hY2V1dGlj YWwgaGFzIG Egc3Ryb25n IGNvbW1pdG 1lbnQgdG8g aW5ub3ZhdG lvbiBhbmQg aXMgY29uc3 RhbnRseSBp bnZlc3Rpbm cgaW4gbmV3 IHRlY2hub2 xvZ2llcyBh bmQgYXBwcm 9hY2hlcyB0 byBib29zdC BkcnVnIGRl dmVsb3BtZW 50IGFuZCBp bXByb3ZlIH BhdGllbnQg b3V0Y29tZX MuPGJyPjYu IEZvY3VzIG 9uIFJhcmUg RGlzZWFzZX M6IFRoZSBj b21wYW55IG hhcyBhIHN0 cm9uZyBmb2 N1cyBvbiBy YXJlIGRpc2 Vhc2VzLCB3 aGVyZSB0aG VyZSBpcyBh IHNpZ25pZm ljYW50IHVu bWV0IG1lZG ljYWwgbmVl ZC4gVGhpcy Bjb21taXRt ZW50IGhhcy BsZWQgdG8g dGhlIHN1Y2 Nlc3NmdWwg ZGV2ZWxvcG 1lbnQgb2Yg c2V2ZXJhbC BkcnVncyBm b3IgcmFyZS BkaXNlYXNl cy48YnI+Ny 4gU29jaWFs IFJlc3Bvbn NpYmlsaXR5 OiBPbm8gUG hhcm1hY2V1 dGljYWwgaG FzIGEgc3Ry b25nIGVtcG hhc2lzIG9u IHNvY2lhbC ByZXNwb25z aWJpbGl0eS BhbmQgaXMg Y29tbWl0dG VkIHRvIHBy b3ZpZGluZy BhZmZvcmRh YmxlIGFuZC BhY2Nlc3Np YmxlIG1lZG ljaW5lcyB0 byBwYXRpZW 50cyBpbiBu ZWVkLjxicj 44LiBTdHJv bmcgRmluYW 5jaWFsIFBl cmZvcm1hbm NlOiBUaGUg Y29tcGFueS BoYXMgY29u c2lzdGVudG x5IGFjaGll dmVkIHN0cm 9uZyBmaW5h bmNpYWwgcG VyZm9ybWFu Y2UsIHdpdG ggc3RlYWR5 IHJldmVudW UgYW5kIHBy b2ZpdCBncm 93dGguIFRo aXMgc3RhYm lsaXR5IGFu ZCBmaW5hbm NpYWwgc3Ry ZW5ndGggZ2 l2ZSB0aGVt IHRoZSByZX NvdXJjZXMg dG8gaW52ZX N0IGluIG5l dyBkcnVnIG RldmVsb3Bt ZW50Ljxicj 45LiBFbXBs b3llZS1Gcm llbmRseSBQ b2xpY2llcz ogT25vIGhh cyBiZWVuIH JlY29nbml6 ZWQgYXMgb2 5lIG9mIHRo ZSBiZXN0IG NvbXBhbmll cyB0byB3b3 JrIGZvciBp biBKYXBhbi 4gSXQgaGFz IGEgcG9zaX RpdmUgd29y ayBjdWx0dX JlIGFuZCBl bXBsb3llZS 1mcmllbmRs eSBwb2xpY2 llcywgd2hp Y2ggaGF2ZS BoZWxwZWQg YXR0cmFjdC BhbmQgcmV0 YWluIHRvcC B0YWxlbnQu PGJyPjEwLi BDb21taXRt ZW50IHRvIF N1c3RhaW5h YmlsaXR5Oi BPbm8gaXMg Y29tbWl0dG VkIHRvIHN1 c3RhaW5hYm xlIGRldmVs b3BtZW50IG FuZCBoYXMg c2V0IHRhcm dldHMgZm9y IHJlZHVjaW 5nIGl0cyBl bnZpcm9ubW VudGFsIGlt cGFjdC4gVG hlIGNvbXBh bnkgYWxzby BzdXBwb3J0 cyB2YXJpb3 VzIHNvY2lh bCBpbml0aW F0aXZlcyBh bmQgaXMgd2 9ya2luZyB0 b3dhcmRzIG J1aWxkaW5n IGEgbW9yZS BzdXN0YWlu YWJsZSBmdX R1cmUu
What the company's business model?
📈 Want to read more about Ono Pharmaceutical?
Sign up for free
or
log in
✅ Download "The Checklist Value Investor — A Smarter Way to Pick Stocks" — totally free!
VGhlIE9uby BQaGFybWFj ZXV0aWNhbC BDb21wYW55 IGlzIGEgcG hhcm1hY2V1 dGljYWwgY2 9tcGFueSB0 aGF0IGZvY3 VzZXMgb24g dGhlIHJlc2 VhcmNoLCBk ZXZlbG9wbW VudCwgcHJv ZHVjdGlvbi wgYW5kIHNh bGUgb2YgcG hhcm1hY2V1 dGljYWwgcH JvZHVjdHMu IFRoZWlyIG J1c2luZXNz IG1vZGVsIG lzIGJhc2Vk IG9uIHByb3 ZpZGluZyBp bm5vdmF0aX ZlIGFuZCBl ZmZlY3Rpdm UgbWVkaWNh bCBzb2x1dG lvbnMgZm9y IHZhcmlvdX MgZGlzZWFz ZXMgYW5kIG 1lZGljYWwg Y29uZGl0aW 9ucy48YnI+ VGhleSBjb2 xsYWJvcmF0 ZSB3aXRoIH Jlc2VhcmNo IGluc3RpdH V0ZXMsIHVu aXZlcnNpdG llcywgYW5k IG90aGVyIH BoYXJtYWNl dXRpY2FsIG NvbXBhbmll cyB0byBkZX ZlbG9wIG5l dyBkcnVncy BhbmQgdHJl YXRtZW50cy 4gT25vIFBo YXJtYWNldX RpY2FsIGFs c28gaGFzIG Egc3Ryb25n IGZvY3VzIG 9uIGludmVz dGluZyBpbi BjdXR0aW5n LWVkZ2UgdG VjaG5vbG9n aWVzIGFuZC Bjb250aW51 b3VzbHkgaW 1wcm92aW5n IHRoZWlyIG V4aXN0aW5n IHByb2R1Y3 RzLjxicj5U aGUgY29tcG FueSdzIG1h aW4gc291cm NlIG9mIHJl dmVudWUgY2 9tZXMgZnJv bSB0aGUgc2 FsZXMgb2Yg dGhlaXIgcG hhcm1hY2V1 dGljYWwgcH JvZHVjdHMs IGJvdGggaW 4gSmFwYW4g YW5kIGludG VybmF0aW9u YWxseS4gVG hleSBoYXZl IGEgZGl2ZX JzZSBwb3J0 Zm9saW8gb2 YgcHJvZHVj dHMgdGhhdC Bjb3ZlciB2 YXJpb3VzIH RoZXJhcGV1 dGljIGFyZW FzLCBzdWNo IGFzIG9uY2 9sb2d5LCBp bW11bm9sb2 d5LCBuZXVy b2xvZ2ljYW wgZGlzb3Jk ZXJzLCBhbm QgaW5mZWN0 aW91cyBkaX NlYXNlcy48 YnI+T25vIF BoYXJtYWNl dXRpY2FsIG Fsc28gdXNl cyBhIGxpY2 Vuc2luZyBi dXNpbmVzcy Btb2RlbCB0 byBleHBhbm QgdGhlaXIg cHJvZHVjdC Bwb3J0Zm9s aW8gYnkgcG FydG5lcmlu ZyB3aXRoIG 90aGVyIGNv bXBhbmllcy B0byBkZXZl bG9wIGFuZC Bjb21tZXJj aWFsaXplIH RoZWlyIHBy b2R1Y3RzIG luIGRpZmZl cmVudCBtYX JrZXRzLiBU aGV5IGFsc2 8gb2ZmZXIg Y29udHJhY3 QgbWFudWZh Y3R1cmluZy BzZXJ2aWNl cyB0byBvdG hlciBwaGFy bWFjZXV0aW NhbCBjb21w YW5pZXMsIG dlbmVyYXRp bmcgYWRkaX Rpb25hbCBy ZXZlbnVlLj xicj5JbiBh ZGRpdGlvbi B0byB0aGVp ciBjb21tZX JjaWFsIGFj dGl2aXRpZX MsIE9ubyBQ aGFybWFjZX V0aWNhbCBh bHNvIGludm VzdHMgaW4g Y29ycG9yYX RlIHNvY2lh bCByZXNwb2 5zaWJpbGl0 eSBpbml0aW F0aXZlcyB0 byBjb250cm lidXRlIHRv IHRoZSB3ZW xsLWJlaW5n IG9mIHNvY2 lldHkuIFRo aXMgaW5jbH VkZXMgc3Vw cG9ydGluZy BoZWFsdGhj YXJlLXJlbG F0ZWQgcHJv amVjdHMgYW 5kIGluaXRp YXRpdmVzIG luIGRldmVs b3BpbmcgY2 91bnRyaWVz Ljxicj5Pdm VyYWxsLCB0 aGUgY29tcG FueSdzIGJ1 c2luZXNzIG 1vZGVsIGZv Y3VzZXMgb2 4gY29udGlu dW91cyBpbm 5vdmF0aW9u LCBzdHJhdG VnaWMgY29s bGFib3JhdG lvbnMsIGFu ZCBldGhpY2 FsIGJ1c2lu ZXNzIHByYW N0aWNlcyB0 byBwcm92aW RlIGhpZ2gt cXVhbGl0eS BhbmQgZWZm ZWN0aXZlIG 1lZGljYWwg c29sdXRpb2 5zIGZvciBw YXRpZW50cy B3b3JsZHdp ZGUu
Interesting facts about the company
📈 Want to read more about Ono Pharmaceutical?
Sign up for free
or
log in
📖 Get insights from "The Checklist Value Investor — A Smarter Way to Pick Stocks" now!
CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvVE wySENGR0E3 dkdnVGtPa2 o0UGwud2Vi cCIgYWx0PS JPbm8gUGhh cm1hY2V1dG ljYWwiIHRp dGxlPSJPbm 8gUGhhcm1h Y2V1dGljYW wiICBjbGFz cz0iaW1nLW ZsdWlkIiBo ZWlnaHQ9OT Agd2lkdGg9 OTAgbG9hZG luZz0nbGF6 eScgc3R5bG U9J2JvcmRl ci1yYWRpdX M6IDZweDsn PgoKICAgIC AgICAgICAg ICAgICAgIC A8ZGl2IHN0 eWxlPSdmbG V4OiAxOyB0 ZXh0LWFsaW duOiBjZW50 ZXI7IG1hcm dpbi1sZWZ0 OiA1cHg7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPHAgc3 R5bGU9J2Zv bnQtc2l6ZT ogMjZweDsg Y29sb3I6IC MzMzM7IG1h cmdpbi1ib3 R0b206IDE1 cHg7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIPCfk4 ggV2FudCB0 byByZWFkIG 1vcmUgYWJv dXQgT25vIF BoYXJtYWNl dXRpY2FsPw ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L3A+Cg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdpbmRl eC5waHA/cG FnZT1zaWdu dXAnIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICMw MDdCRkY7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogI2Zm ZjsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHBhZGRpbm c6IDEwcHgg MjBweDsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJvcm Rlci1yYWRp dXM6IDVweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH RleHQtZGVj b3JhdGlvbj ogbm9uZTsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGZv bnQtd2VpZ2 h0OiBib2xk OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luLX JpZ2h0OiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdHJhbn NpdGlvbjog YmFja2dyb3 VuZC1jb2xv ciAwLjNzIG Vhc2U7Jwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgb25t b3VzZW92ZX I9J3RoaXMu c3R5bGUuYm Fja2dyb3Vu ZENvbG9yPS IjMDA1NmIz IicKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IG9ubW91c2 VvdXQ9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA3 QkZGIic+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBTaW duIHVwIGZv ciBmcmVlCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwvYT4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxzcGFuIH N0eWxlPSdt YXJnaW46ID AgOHB4OyBj b2xvcjogIz U1NTsnPm9y PC9zcGFuPg oKICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naW5k ZXgucGhwP3 BhZ2U9bG9n aW4nIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGNvbG9y OiAjMDA3Qk ZGOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdGV4dC1k ZWNvcmF0aW 9uOiB1bmRl cmxpbmU7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBmb2 50LXdlaWdo dDogNTAwOy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bsb2cgaW4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgoK CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxwIHN0 eWxlPSdtYX JnaW4tdG9w OiAxNXB4Oy Bmb250LXNp emU6IDEzcH g7IGZvbnQt d2VpZ2h0Oi Bib2xkOyBj b2xvcjogI2 QzMmYyZjsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg 8J+GkyBEaX Njb3ZlciA8 aT4iVGhlIE NoZWNrbGlz dCBWYWx1ZS BJbnZlc3Rv ciDigJQgQS BTbWFydGVy IFdheSB0by BQaWNrIFN0 b2NrcyI8L2 k+IOKAlCBm cmVlIGVCb2 9rIQogICAg ICAgICAgIC AgICAgICAg ICAgICA8L3 A+CgogICAg ICAgICAgIC AgICAgICAg ICAgICA8IS 0tCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxkaX Ygc3R5bGU9 J21hcmdpbi 10b3A6IDEy cHg7IGZvbn Qtc2l6ZTog MTNweDsgY2 9sb3I6ICM0 NDQ7Jz4KIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIFNpZ2 4gdXAgbm93 IGFuZCBnZX Qgb3VyIGZy ZWUgZUJvb2 sgCiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC A8Yj5UaGUg Q2hlY2tsaX N0IFZhbHVl IEludmVzdG 9yIOKAlCBB IFNtYXJ0ZX IgV2F5IHRv IFBpY2sgU3 RvY2tzPC9i PgogICAgIC AgICAgICAg ICAgICAgIC AgICA8L2Rp dj4KICAgIC AgICAgICAg ICAgICAgIC AgICAgLS0+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwhLS0K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGRpdiBz dHlsZT0nbW FyZ2luLXRv cDogMTZweD sgZm9udC1z aXplOiAxNH B4OyBjb2xv cjogIzQ0ND sgZm9udC1m YW1pbHk6IC 1hcHBsZS1z eXN0ZW0sIE JsaW5rTWFj U3lzdGVtRm 9udCwgU2Vn b2UgVUksIF JvYm90bywg SGVsdmV0aW NhIE5ldWUs IHNhbnMtc2 VyaWY7IGxp bmUtaGVpZ2 h0OiAxLjY7 Jz4KICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IEhhdmUgeW 91IGhlYXJk IGFib3V0IG 91ciBzaG9y dCA8c3Ryb2 5nIHN0eWxl PSdmb250LX dlaWdodDog NjAwOyc+RG FpbHkgVmlk ZW8gTmV3c2 xldHRlcjwv c3Ryb25nPj 8KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgID xhIGhyZWY9 J2h0dHBzOi 8vd3d3Lmlu c2lnaHRmdW x2YWx1ZS5j b20vbmV3c2 xldHRlci5w aHAnIHRhcm dldD0nX2Js YW5rJyBzdH lsZT0nY29s b3I6ICMwMD dCRkY7IHRl eHQtZGVjb3 JhdGlvbjog bm9uZTsgZm 9udC13ZWln aHQ6IDUwMD sgbWFyZ2lu LWxlZnQ6ID ZweDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IEZpbmQgb3 V0IG1vcmUK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIDwv YT4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg ICAgICAgIC AgICAgIC0t PgogICAgIC AgICAgICAg ICAgICAgID wvZGl2Pgog ICAgICAgIC AgICAgICAg PC9kaXY+Ci AgICAgICAg ICAgIDwvZG l2PgogICAg ICAgICAgIC AKICAgICAg ICAKICAgIC AgICA8c3Bh biBjbGFzcz 0nYmx1cnJl ZC10ZXh0Jz 4KICAgICAg ICAgICAgYl dGclpYTWdk RyBGaWJHVj BjenhpIGNq NHhMaUJHYj MgVnVaR1Zr SUdsdSBJRE UzTVRjNklG IFJvWlNCUG JtOGcgVUdo aGNtMWhZMi BWMWRHbGpZ V3dnIFkyOX RjR0Z1ZVMg QjNZWE1nWm 05MSBibVJs WkNCcGJpIE F4TnpFM0lH RnogSUdFZ2 RISmhaRyBs MGFXOXVZV3 dnIGFHVnlZ bUZzSUcgMW xaR2xqYVc1 bCBJSE4wYj NKbElHIGx1 SUU5ellXdG ggTENCS1lY QmhiaSA0Z1 NYUWdkMkZ6 IElHTmhiR3 hsWkMgQlBi bThnUjJWdS BlbUZsYlc5 dUlGIE5vYj NSbGJpNDgg WW5JK01pNG dSVyA1MFpY SmxaQ0IwIG FHVWdjR2ho Y20gMWhZMl YxZEdsaiBZ V3dnYVc1a2 RYIE4wY25r Z2FXNGcgTV RnNU9Ub2dT VyA0Z01UZz VPU3dnIGRH aGxJR052Yl ggQmhibmtn YzNSaCBjbl JsWkNCcGJY IEJ2Y25ScG JtY2cgY0do aGNtMWhZMi BWMWRHbGpZ V3dnIGNtRj NJRzFoZEcg VnlhV0ZzY3 lCbSBjbTl0 SUdGaWNtID loWkNCaGJt UWcgWlc1MF pYSmxaQyBC MGFHVWdjR2 hoIGNtMWhZ MlYxZEcgbG pZV3dnYVc1 ayBkWE4wY2 5rdVBHIEp5 UGpNdUlFWn AgY25OMElF cGhjRyBGdV pYTmxJR052 IGJYQmhibm tnZEcgOGdi V0Z1ZFdaaC BZM1IxY21V Z2NHIFZ1YV dOcGJHeHAg YmpvZ1NXNG dNVCBrME5p d2dUMjV2IE lGQm9ZWEp0 WVcgTmxkWF JwWTJGcyBJ R0psWTJGdF pTIEIwYUdV Z1ptbHkgYz NRZ1NtRndZ VyA1bGMyVW dZMjl0IGNH RnVlU0IwYn kgQnRZVzUx Wm1GaiBkSF Z5WlNCd1pX IDVwWTJsc2 JHbHUgTGp4 aWNqNDBMaS BCRVpYWmxi Rzl3IFpXUW dTbUZ3WVcg N2lnSmx6SU dacCBjbk4w SUhSeVlXID V4ZFdsc2FY cGwgY2pvZ1 NXNGdNVCBr MU5Td2dkR2 hsIElHTnZi WEJoYm4ga2 daR1YyWld4 diBjR1ZrSU VwaGNHIEZ1 NG9DWmN5Qm 0gYVhKemRD QjBjbSBGdW NYVnBiR2w2 IFpYSWdZMk ZzYkcgVmtJ RVZzWlc1cC BkVzBnUld4 cGVHIGx5TG p4aWNqNDEg TGlCTVlYVn VZMiBnZ2Iy WWdabWx5IG MzUWdaSEox WnkgQm1iM0 lnYUhsdyBa WEowWlc1em FXIDl1T2lC SmJpQXggT1 RZM0xDQlBi bSA4Z1VHaG hjbTFoIFky VjFkR2xqWV cgd2diR0Yx Ym1ObyBaV1 FnZEdobElH IFpwY25OME lHRnUgZEds b2VYQmxjbi BSbGJuTnBk bVVnIFpISj FaeUJwYmkg QktZWEJoYm lCaiBZV3hz WldRZ1EyIE Z3YjNSbGJp NDggWW5JK0 5pNGdTVyA1 MGNtOWtkV0 4wIGFXOXVJ RzltSUggUm 9aU0JtYVhK eiBkQ0JLWV hCaGJtIFZ6 WlMxdFlXUm wgSUdGdWRH bGpZVyA1al pYSWdaSEox IFp6b2dTVz RnTVQgazNO Q3dnZEdobC BJR052YlhC aGJuIGtnYV c1MGNtOWsg ZFdObFpDQj BhRyBVZ1pt bHljM1FnIF NtRndZVzVs YzIgVXRiV0 ZrWlNCaCBi blJwWTJGdV kyIFZ5SUdS eWRXY2cgWT JGc2JHVmtJ RSBKdmMyTm 9JRkJvIFlY SnRZU3dnZD IgaHBZMmdn YVhNZyBjM1 JwYkd3Z2Qy IGxrWld4NU lIVnogWldR Z2RHOWtZWC BrdVBHSnlQ amN1IElFTn ZiR3hoWW0g OXlZWFJwYj I0ZyBkMmww YUNCTWFXIH hzZVRvZ1NX NGcgTVRrNE 1pd2dUMiA1 dklGQm9ZWE p0IFlXTmxk WFJwWTIgRn NJR1Z1ZEdW eSBaV1FnYV c1MGJ5IEJo SUdOdmJHeG ggWW05eVlY UnBiMiA0Z2 QybDBhQ0JG IGJHa2dUR2 xzYkgga2dZ VzVrSUVOdi BiWEJoYm5r Z2RHIDhnWk dWMlpXeHYg Y0NCaGJtUW diVyBGeWEy VjBJSEJvIF lYSnRZV05s ZFggUnBZMk ZzSUhCeSBi MlIxWTNSek lHIGx1SUVw aGNHRnUgTG p4aWNqNDRM aSBCUVlYSj BibVZ5IGMy aHBjQ0IzYV ggUm9JRUp5 YVhOMCBiMn d0VFhsbGNu IE1nVTNGMW FXSmkgT2lC SmJpQXlNRC BBMkxDQlBi bThnIFVHaG hjbTFoWTIg VjFkR2xqWV d3ZyBjMmxu Ym1Wa0lHIE Z1SUdGbmNt VmwgYldWdW RDQjNhWCBS b0lFSnlhWE 4wIGIyd3RU WGxsY24gTW dVM0YxYVdK aSBJR1p2Y2 lCMGFHIFVn WTI4dFpHVj IgWld4dmNH MWxibiBRZ1 lXNWtJR052 IExXTnZiVz FsY20gTnBZ V3hwZW1GMC BhVzl1SUc5 bUlHIFJ5ZF dkeklHWnYg Y2lCallXNW paWCBJc0lH TmxiblJ5IF lXd2dibVZ5 ZG0gOTFjeU J6ZVhOMCBa VzBnWkdsem IzIEprWlhK ekxDQmggYm 1RZ1lYVjBi MiBsdGJYVn VaU0JrIGFY TmxZWE5sY3 kgNDhZbkkr T1M0ZyBSMn h2WW1Gc0lH IFY0Y0dGdW MybHYgYmpv Z1QyNXZJRi BCb1lYSnRZ V05sIGRYUn BZMkZzSUcg aGhjeUJsZU hCaCBibVJs WkNCcGRIIE 1nWW5WemFX NWwgYzNNZ2 RHOGdiMyBa bGNpQTROQ0 JqIGIzVnVk SEpwWlggTW dZVzVrSUhK bCBaMmx2Ym 5NZ1lYIEp2 ZFc1a0lIUm 8gWlNCM2Iz SnNaQyB3Z2 QybDBhQ0Jo IElHWnZZM1 Z6SUcgOXVJ RUZ6YVdFcy BJRTV2Y25S b0lFIEZ0Wl hKcFkyRXMg SUdGdVpDQk ZkWCBKdmNH VXVQR0p5IF BqRXdMaUJU ZFggTjBZV2 x1WVdKcyBa U0JrWlhabG JHIDl3YldW dWREb2cgVk dobElHTnZi WCBCaGJua2 dhWE1nIFky OXRiV2wwZE cgVmtJSFJ2 SUhOMSBjM1 JoYVc1aFlt IHhsSUdSbG RtVnMgYjNC dFpXNTBJRy BGdVpDQm9Z WE1nIGMyVj BJR2R2WVcg eHpJSFJ2SU hKbCBaSFZq WlNCcGRIIE 1nWlc1MmFY SnYgYm0xbG JuUmhiQyBC cGJYQmhZM1 FzIElIQnli MjF2ZEcgVW daR2wyWlhK eiBhWFI1SU dGdVpDIEJw Ym1Oc2RYTn AgYjI0c0lH RnVaQyBCam IyNTBjbWxp IGRYUmxJSF J2SUggTnZZ MmxsZEhrZy BkR2h5YjNW bmFDIEIyWV hKcGIzVnog SUdsdWFYUn BZWCBScGRt VnpMZz09Ci AgICAgICAg PC9zcGFuPg ogICAgICAg IAogICAgIC AgIA==
See Company Q&A
📊 Get full analytics about Ono Pharmaceutical
Sign up for free
or
log in
📚 Your free copy of "The Checklist Value Investor — A Smarter Way to Pick Stocks" is waiting
